EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment

Junfeng Xu, Na Li, Hui Xie, Changwei Duan, Xingchen Liao, Ruoran Li, Heng Zhang, Yuanming Pan, Xianzong Ma, Shuwen Du, Jianqiu Sheng, Xin Wang und 2 weitere

Translational Oncology · 2025-03 · 53 · 102310

DOI: 10.1016/j.tranon.2025.102310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2025-03. Verfasst von Junfeng Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, PR China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colony-stimulating factor 3 (CSF3) is a cytokine that promotes inflammation by stimulating the maturation, proliferation, and trafficking of myeloid progenitor cells. However, the functional importance of CSF3 in colorectal cancer (CRC) remains unclear. METHODS: CSF3 expression levels in CRC cells and tissues were detected by quantitative real-time PCR (qRT-PCR), western blot and immunohistochemistry (IHC). In vitro and in vivo assays were performed to investigate the oncogenic function of CSF3 in the tumor associated malignant phenotypes and the tumorigenic capability of CRC cells. Immunocoprecipitation was performed to verify the regulatory effects of CSF3 on IκBα ubiquitination. RESULTS: We found that CSF3 was overexpressed in CRC tissues compared to adjacent normal tissues, which correlated with poor patient survival. In vitro, silencing CSF3 significantly impaired cell proliferation, colony formation, and migration, while enhancing apoptosis. In vivo, silencing CSF3 resulted in reduced tumor growth, weight, and volume, indicating its potential as a therapeutic target. Mechanistically, CSF3 was found to mediate CRC development by activating the NF-κB signaling pathway, as evidenced by the decreased phosphorylation of p65 and reduced IκBα ubiquitination in CSF3-silenced cells. Furthermore, CSF3 silencing modulated immune infiltration in CRC, promoting an anti-tumor immune response and altering the tumor microenvironment. CONCLUSION: CSF3 modulated the NF-κB signaling pathway through a distinct mechanism involving p65 phosphorylation and the activation of NF-κB by enhancing IκBα ubiquitination, thereby effectively promoting CRC development, and CSF3 may serve as a potential therapeutic target for repressing CRC advance and metastasis.

Schlagwörter

Stichwörter der Autor:innen

CSF3Colorectal cancerTumor microenvironmentUbiquitinationp65/NF-κB signaling

Autor:innen und Institutionen

  • Senior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, PR China.
  • Senior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, PR China; Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beij…
  • Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, PR China.
  • Medical School of Chinese PLA, Beijing 100853, PR China.
  • Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing 101149, PR China.
  • Department of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, PR China. Electronic address: wangxin1@301hospital.com.cn.

Förderung

  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • National Natural Science Foundation of China

Zitieren

APA

Xu, J., Li, N., Xie, H., Duan, C., Liao, X., Li, R., Zhang, H., Pan, Y., Ma, X., Du, S., Sheng, J., Wang, X., Yang, L., & Jin, P. (2025). CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment. Translational Oncology, 53, 102310. https://doi.org/10.1016/j.tranon.2025.102310

Vancouver

Xu J, Li N, Xie H, Duan C, Liao X, Li R, et al. CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment. Translational Oncology. 2025;53:102310. doi:10.1016/j.tranon.2025.102310

BibTeX
@article{Xu2025,
  author = {Xu, Junfeng and Li, Na and Xie, Hui and Duan, Changwei and Liao, Xingchen and Li, Ruoran and Zhang, Heng and Pan, Yuanming and Ma, Xianzong and Du, Shuwen and Sheng, Jianqiu and Wang, Xin and Yang, Lang and Jin, Peng},
  title = {CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment},
  journal = {Translational Oncology},
  year = {2025},
  volume = {53},
  pages = {102310},
  doi = {10.1016/j.tranon.2025.102310}
}
Kostenlos starten →